Skip to main content
. 2018 Sep 25;68(7):1224–1231. doi: 10.1136/gutjnl-2018-316794

Figure 2.

Figure 2

Kaplan-Meier curves of time to CDI recurrence during trial. The figure shows most relapses in the rifaximin group occurred between 50 and 100 days. Recurrence in the placebo group mostly occurred earlier. CDI, Clostridium difficile infection.